Zurabio
we are planning to initiate two phase studies in | Zurabio
Company
Deck Type
Deck date
June 2022
Slide
25 of 30
Related slides by other companies
NeuroSense Therapeutics
Investor Presentation
December 2023
milestones achieved and upcoming potential catalysts | NeuroSense Therapeutics
Alkermes
Investor Day
March 2021
disciplined capital allocation supports highest roi priorities develop next generation of pipeline candidates complete phase enabling activities initiate phase first in human study initiate phase study nominate candidate to the clinic oncology lead candidate generation advance lead candidate identification | Alkermes
RenovoRx
IPO
August 2021
designed for success one phase trial to approval pivotal tiger pac phase study schema currently enrolling | RenovoRx
Xeris Biopharma
Investor Presentation
October 2022
topline results of phase study of | Xeris Biopharma
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights